Advancing clinical journey with our partners

Isotopia's Home page » News » Advancing clinical journey with our partners

Partnerin with Radiopharm (ASX:RAD) to extend the clinical journey to find the best therapies against cancer.

More To Explore

The unmet need for 177-Lu-PSMA radioligand therapy in America for mCRPC patients

Marketing Authorization - Isotopia ltd

Marketing Authorization - Isotopia ltd

Isotopia is expanding its global footprint after filling a DMF in the US FDA and MF in Canada

Is there a future for PSMA theranostics in Osteosarcoma?